During the stress of the pandemic and political unrest in the U.S., pet food companies, government regulators, diagnostics laboratories and other need to work together and remain vigilant to other threats.

Regulatory complications to using CBD in pet products continue to be a challenge for use in pet food and treat products, according to experts.

MSBC’s status in pet food and the changing of vitamin names on pet food labels required special attention from the Ingredient Definitions Committee after AAFCO's 2020 Annual Meeting.

It’s important to know AAFCO pet food ingredient definitions and nuances; otherwise inaccurate conclusions can result, such as with the DCM investigation.

After near silence on the DCM and grain-free pet food investigation and no real updates for a year, FDA has issued statements that raise more questions.

Officials with the U.S. Food and Drug Administration Center for Veterinary Medicine released several documents and statements about the agency’s investigation into correlations between specific dog foods and cases of canine dilated cardiomyopathy.

FDA’s recent, very quiet update on its grain-free pet food-DCM investigation showed that, no surprise, it’s a complex issue that can’t be pinned to one cause.

The Ingredient Definitions Committee session at the AAFCO Annual Meeting covered a lot of ground, including a new workshop, the current standing of several definitions, and next steps for future topics.

Mars believes that Simmons infringed on Pedigree’s trade dress by using the same label colors and design elements.

Depending on how that policy ends up, FDA could issue more warning letters to pet product companies using CBD in their formulations.